6 completed. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 1 | Completed 1 |
Follow Shingles: new trials by email Literature Review of Shingles trials Research Report on Shingles
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025) Zoster Vaccine Live - Herpes Zoster, Shingles | Phase 3 | Completed | Merck Sharp & Dohme LLC | 250 | 2012-10-31 | 2018-09-18 |
| Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1) Zoster Vaccine, Live (AMP), Zoster Vaccine, Live - Herpes Zoster, Shingles | Phase 3 | Completed | Merck Sharp & Dohme LLC | 498 | 2012-04-01 | 2017-04-12 |
| Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022) Zoster Vaccine, Live (Zostavax™), Comparator: Placebo - Shingles | Phase 3 | Completed | Merck Sharp & Dohme LLC | 22439 | 2007-10-01 | 2017-04-12 |
| Study of NGX-4010 for the Treatment of Postherpetic Neuralgia NGX-4010 - Peripheral Nervous System Diseases, Pain | Phase 3 | Completed | NeurogesX | 400 | 2006-03-01 | 2008-03-06 |
| Study of NGX-4010 for the Treatment of Postherpetic Neuralgia NGX-4010 - Peripheral Nervous System Diseases, Pain | Phase 3 | Completed | NeurogesX | 400 | 2005-06-01 | 2008-03-06 |
| NGX-4010 for the Treatment of Postherpetic Neuralgia Capsaicin Dermal Patch - Herpes Zoster, Neuralgia | Phase 2 / Phase 3 | Completed | NeurogesX | 300 | 2008-03-06 |
Herpes Zoster (6) · Neuralgia (3) · Pain (3) · Peripheral Nervous System Diseases (3) · Neuralgia, Postherpetic (2)
DNA Virus Infections (6) · Herpesviridae Infections (6) · Infections (6) · Varicella Zoster Virus Infection (6) · Virus Diseases (6) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Neuromuscular Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3)
Herpes Zoster Vaccine (3) · Capsaicin (2) · Adenosine Monophosphate (1)
Merck Sharp & Dohme LLC (3) · NeurogesX (3)
United States (1)
PMID 18977178, PMID 21087403, PMID 22291101, PMID 23908486, PMID 24823623, PMID 31325263, PMID 37781954